Biolife Solutions (BLFS) Cash from Financing Activities (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cash from Financing Activities data on file, last reported at -$7.9 million in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$7.9 million, down 163.87% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.8 million (down 79.38% YoY), and the FY2025 annual result was -$10.9 million, down 61.05% from the prior year.
• Cash from Financing Activities declined to -$7.9 million in Q1 2026 per BLFS's latest filing, from -$2.5 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $17.4 million in Q3 2022 and troughed at -$7.9 million in Q1 2026.
• A 5-year average of $76764.7 and a median of -$704000.0 in 2024 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities jumped 1745.65% in 2022, then plunged 308.81% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$625000.0 in 2022, then jumped by 1674.56% to $9.8 million in 2023, then tumbled by 141.52% to -$4.1 million in 2024, then jumped by 38.91% to -$2.5 million in 2025, then slumped by 216.31% to -$7.9 million in 2026.
• Business Quant data shows BLFS's Cash from Financing Activities at -$7.9 million in Q1 2026, -$2.5 million in Q4 2025, and -$2.6 million in Q3 2025.